Literature DB >> 34919146

How mutant isocitrate dehydrogenase orchestrates immune cells.

Lukas Bunse1,2, Michael Platten1,2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34919146      PMCID： PMC8804880          DOI： 10.1093/neuonc/noab266

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  9 in total

1.  Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells.

Authors:  Florian Klemm; Roeltje R Maas; Robert L Bowman; Mara Kornete; Klara Soukup; Sina Nassiri; Jean-Philippe Brouland; Christine A Iacobuzio-Donahue; Cameron Brennan; Viviane Tabar; Philip H Gutin; Roy T Daniel; Monika E Hegi; Johanna A Joyce
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

2.  Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes.

Authors:  Ekaterina Friebel; Konstantina Kapolou; Susanne Unger; Nicolás Gonzalo Núñez; Sebastian Utz; Elisabeth Jane Rushing; Luca Regli; Michael Weller; Melanie Greter; Sonia Tugues; Marian Christoph Neidert; Burkhard Becher
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

3.  Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

Authors:  Gary Kohanbash; Diego A Carrera; Shruti Shrivastav; Brian J Ahn; Naznin Jahan; Tali Mazor; Zinal S Chheda; Kira M Downey; Payal B Watchmaker; Casey Beppler; Rolf Warta; Nduka A Amankulor; Christel Herold-Mende; Joseph F Costello; Hideho Okada
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

4.  A vaccine targeting mutant IDH1 induces antitumour immunity.

Authors:  Theresa Schumacher; Lukas Bunse; Stefan Pusch; Felix Sahm; Benedikt Wiestler; Jasmin Quandt; Oliver Menn; Matthias Osswald; Iris Oezen; Martina Ott; Melanie Keil; Jörg Balß; Katharina Rauschenbach; Agnieszka K Grabowska; Isabel Vogler; Jan Diekmann; Nico Trautwein; Stefan B Eichmüller; Jürgen Okun; Stefan Stevanović; Angelika B Riemer; Ugur Sahin; Manuel A Friese; Philipp Beckhove; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

5.  Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.

Authors:  Lukas Bunse; Stefan Pusch; Theresa Bunse; Felix Sahm; Khwab Sanghvi; Mirco Friedrich; Dalia Alansary; Jana K Sonner; Edward Green; Katrin Deumelandt; Michael Kilian; Cyril Neftel; Stefanie Uhlig; Tobias Kessler; Anna von Landenberg; Anna S Berghoff; Kelly Marsh; Mya Steadman; Dongwei Zhu; Brandon Nicolay; Benedikt Wiestler; Michael O Breckwoldt; Ruslan Al-Ali; Simone Karcher-Bausch; Matthias Bozza; Iris Oezen; Magdalena Kramer; Jochen Meyer; Antje Habel; Jessica Eisel; Gernot Poschet; Michael Weller; Matthias Preusser; Minou Nadji-Ohl; Niklas Thon; Michael C Burger; Patrick N Harter; Miriam Ratliff; Richard Harbottle; Axel Benner; Daniel Schrimpf; Jürgen Okun; Christel Herold-Mende; Sevin Turcan; Stefan Kaulfuss; Holger Hess-Stumpp; Karen Bieback; Daniel P Cahill; Karl H Plate; Daniel Hänggi; Marion Dorsch; Mario L Suvà; Barbara A Niemeyer; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nat Med       Date:  2018-07-09       Impact factor: 53.440

6.  Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.

Authors:  Padma Kadiyala; Stephen V Carney; Jessica C Gauss; Maria B Garcia-Fabiani; Santiago Haase; Mahmoud S Alghamri; Felipe J Núñez; Yayuan Liu; Minzhi Yu; Ayman Taher; Fernando M Nunez; Dan Li; Marta B Edwards; Celina G Kleer; Henry Appelman; Yilun Sun; Lili Zhao; James J Moon; Anna Schwendeman; Pedro R Lowenstein; Maria G Castro
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

7.  Mutant IDH1 regulates the tumor-associated immune system in gliomas.

Authors:  Nduka M Amankulor; Youngmi Kim; Sonali Arora; Julia Kargl; Frank Szulzewsky; Mark Hanke; Daciana H Margineantu; Aparna Rao; Hamid Bolouri; Jeff Delrow; David Hockenbery; A McGarry Houghton; Eric C Holland
Journal:  Genes Dev       Date:  2017-05-02       Impact factor: 11.361

8.  A vaccine targeting mutant IDH1 in newly diagnosed glioma.

Authors:  Michael Platten; Lukas Bunse; Antje Wick; Theresa Bunse; Lucian Le Cornet; Inga Harting; Felix Sahm; Khwab Sanghvi; Chin Leng Tan; Isabel Poschke; Edward Green; Sune Justesen; Geoffrey A Behrens; Michael O Breckwoldt; Angelika Freitag; Lisa-Marie Rother; Anita Schmitt; Oliver Schnell; Jörg Hense; Martin Misch; Dietmar Krex; Stefan Stevanovic; Ghazaleh Tabatabai; Joachim P Steinbach; Martin Bendszus; Andreas von Deimling; Michael Schmitt; Wolfgang Wick
Journal:  Nature       Date:  2021-03-24       Impact factor: 49.962

9.  Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles.

Authors:  Nils Ludwig; Aparna Rao; Poorva Sandlesh; Saigopalakrishna S Yerneni; Alexander D Swain; Kristin M Bullock; Kim M Hansen; Xiaoran Zhang; Emade Jaman; Jordan Allen; Katharine Krueger; Chang-Sook Hong; William A Banks; Theresa L Whiteside; Nduka M Amankulor
Journal:  Neuro Oncol       Date:  2022-02-01       Impact factor: 13.029
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.